Description

Gujarat Kidney And Super Speciality Limited equity shares to be listed on NSE Capital Market segment with effect from December 30, 2025.

Summary

National Stock Exchange of India has notified the listing of equity shares of Gujarat Kidney And Super Speciality Limited (Symbol: GKSL) on the Capital Market segment effective December 30, 2025. The company issued 78,843,250 equity shares of face value Rs. 2/- each at an issue price of Rs. 114/- per share. The security will be part of the pre-open session for IPO category as per SEBI circular guidelines.

Key Points

  • Symbol: GKSL
  • ISIN: INE0V0W01025
  • Series: EQ
  • Face Value: Rs. 2/- per share
  • Issue Price: Rs. 114/- per share
  • Total Shares Issued: 78,843,250 equity shares
  • Market Lot: 1 share
  • Pari Passu: Yes
  • Pre-open Session: Applicable for IPO category
  • Registrar: MUFG Intime India Private Limited (formerly Link Intime India Private Limited)

Regulatory Changes

No regulatory changes introduced. This circular is a standard listing notification under Regulation 3.1.1 and 2.5.5 of NSE Capital Market Trading Regulations Part A.

Compliance Requirements

  • Members must identify the security by its designated code (GKSL) for trading purposes
  • Trading shall be conducted in the specified market lot size of 1 share
  • The security will participate in pre-open session as per SEBI circular no. CIR/MRD/DP/01/2012 & CIR/MRD/DP/02/2012 dated January 20, 2012

Important Dates

  • Circular Date: December 29, 2025
  • Effective Date: December 30, 2025
  • Financial Year: April 2025 - March 2026
  • Lock-in Periods: Various tranches with lock-in dates ranging from January 24, 2026 to January 2, 2029 (detailed in Annexure I)
    • 13,226,880 shares are free from lock-in
    • Multiple tranches locked until July 2, 2026, January 24-25, 2026, March 25, 2026, January 2, 2027, and January 2, 2029

Impact Assessment

Market Impact: Low - This is a routine IPO listing in the healthcare/hospital sector. The company operates kidney and super-specialty hospital services based in Vadodara, Gujarat.

Investor Impact: Medium for IPO participants and healthcare sector investors. The listing provides liquidity to IPO allottees and enables secondary market trading.

Operational Impact: Standard listing procedures apply. Trading members can commence trading from December 30, 2025 in the specified lot size.

Company Details:

  • Registered Office: Plot No. 1, City Survey No. 1537/A, Jetalpur Road, Gokak Mill Compound, Alkapuri, Vadodara – 390020, Gujarat
  • Contact: +91 265 298 4800
  • Website: www.gujaratsuperspecialityhospital.com
  • Company Secretary: Ms. Niki Paresh Tiwari

Impact Justification

Standard IPO listing notification with medium importance for investors interested in healthcare sector stocks, low overall market impact as it affects only new listing participants